392 related articles for article (PubMed ID: 31744449)
1. Mitochondrion as a Selective Target for the Treatment of Atherosclerosis: Role of Mitochondrial DNA Mutations and Defective Mitophagy in the Pathogenesis of Atherosclerosis and Chronic Inflammation.
Orekhov AN; Poznyak AV; Sobenin IA; Nikifirov NN; Ivanova EA
Curr Neuropharmacol; 2020; 18(11):1064-1075. PubMed ID: 31744449
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial Dysfunction in Vascular Wall Cells and Its Role in Atherosclerosis.
Salnikova D; Orekhova V; Grechko A; Starodubova A; Bezsonov E; Popkova T; Orekhov A
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445694
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial Respiration Is Reduced in Atherosclerosis, Promoting Necrotic Core Formation and Reducing Relative Fibrous Cap Thickness.
Yu EPK; Reinhold J; Yu H; Starks L; Uryga AK; Foote K; Finigan A; Figg N; Pung YF; Logan A; Murphy MP; Bennett M
Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2322-2332. PubMed ID: 28970293
[TBL] [Abstract][Full Text] [Related]
4. Genetics of Arterial-Wall-Specific Mechanisms in Atherosclerosis: Focus on Mitochondrial Mutations.
Orekhov AN; Ivanova EA; Markin AM; Nikiforov NG; Sobenin IA
Curr Atheroscler Rep; 2020 Aug; 22(10):54. PubMed ID: 32772280
[TBL] [Abstract][Full Text] [Related]
5. Do Mitochondrial DNA Mutations Play a Key Role in the Chronification of Sterile Inflammation? Special Focus on Atherosclerosis.
Orekhov AN; Gerasimova EV; Sukhorukov VN; Poznyak AV; Nikiforov NG
Curr Pharm Des; 2021; 27(2):276-292. PubMed ID: 33045961
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial DAMPs and altered mitochondrial dynamics in OxLDL burden in atherosclerosis.
Khwaja B; Thankam FG; Agrawal DK
Mol Cell Biochem; 2021 Apr; 476(4):1915-1928. PubMed ID: 33492610
[TBL] [Abstract][Full Text] [Related]
7. Targeting mitochondrial function in macrophages: A novel treatment strategy for atherosclerotic cardiovascular disease?
Becker PH; Thérond P; Gaignard P
Pharmacol Ther; 2023 Jul; 247():108441. PubMed ID: 37201736
[TBL] [Abstract][Full Text] [Related]
8. Role of PGC-1α in Vascular Regulation: Implications for Atherosclerosis.
Kadlec AO; Chabowski DS; Ait-Aissa K; Gutterman DD
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1467-74. PubMed ID: 27312223
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial Dysfunction: The Hidden Player in the Pathogenesis of Atherosclerosis?
Ciccarelli G; Conte S; Cimmino G; Maiorano P; Morrione A; Giordano A
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674602
[TBL] [Abstract][Full Text] [Related]
10. Atherosclerosis as Mitochondriopathy: Repositioning the Disease to Help Finding New Therapies.
Shemiakova T; Ivanova E; Wu WK; Kirichenko TV; Starodubova AV; Orekhov AN
Front Cardiovasc Med; 2021; 8():660473. PubMed ID: 34017868
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
12. Effects of mitochondrial dysfunction on cellular function: Role in atherosclerosis.
Xu M; Wang W; Cheng J; Qu H; Xu M; Wang L
Biomed Pharmacother; 2024 May; 174():116587. PubMed ID: 38636397
[TBL] [Abstract][Full Text] [Related]
13. Mitophagy acts as a safeguard mechanism against human vascular smooth muscle cell apoptosis induced by atherogenic lipids.
Swiader A; Nahapetyan H; Faccini J; D'Angelo R; Mucher E; Elbaz M; Boya P; Vindis C
Oncotarget; 2016 May; 7(20):28821-35. PubMed ID: 27119505
[TBL] [Abstract][Full Text] [Related]
14. Cellular Mechanisms of Human Atherogenesis: Focus on Chronification of Inflammation and Mitochondrial Mutations.
Markin AM; Sobenin IA; Grechko AV; Zhang D; Orekhov AN
Front Pharmacol; 2020; 11():642. PubMed ID: 32528276
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial mutations in atherosclerosis: new solutions in research and possible clinical applications.
Sobenin IA; Chistiakov DA; Bobryshev YV; Postnov AY; Orekhov AN
Curr Pharm Des; 2013; 19(33):5942-53. PubMed ID: 23438955
[TBL] [Abstract][Full Text] [Related]
16. The role of mitochondrial DNA damage in the development of atherosclerosis.
Yu EP; Bennett MR
Free Radic Biol Med; 2016 Nov; 100():223-230. PubMed ID: 27320189
[TBL] [Abstract][Full Text] [Related]
17. PINK1/Parkin-mediated mitophagy promotes apelin-13-induced vascular smooth muscle cell proliferation by AMPKα and exacerbates atherosclerotic lesions.
He L; Zhou Q; Huang Z; Xu J; Zhou H; Lv D; Lu L; Huang S; Tang M; Zhong J; Chen JX; Luo X; Li L; Chen L
J Cell Physiol; 2019 Jun; 234(6):8668-8682. PubMed ID: 30456860
[TBL] [Abstract][Full Text] [Related]
18. [Pathways for maintenance of mitochondrial DNA integrity and mitochondrial functions in cells exposed to ionizing radiation].
Gaziev AI
Radiats Biol Radioecol; 2013; 53(2):117-36. PubMed ID: 23786028
[TBL] [Abstract][Full Text] [Related]
19. Disturbance of Mitochondrial Dynamics and Mitochondrial Therapies in Atherosclerosis.
Markin AM; Khotina VA; Zabudskaya XG; Bogatyreva AI; Starodubova AV; Ivanova E; Nikiforov NG; Orekhov AN
Life (Basel); 2021 Feb; 11(2):. PubMed ID: 33672784
[TBL] [Abstract][Full Text] [Related]
20. The alterations of mitochondrial DNA in coronary heart disease.
Hu H; Lin Y; Xu X; Lin S; Chen X; Wang S
Exp Mol Pathol; 2020 Jun; 114():104412. PubMed ID: 32113905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
